baber/WOPTO huggingface dataset:
Patent NZ-334808-A (NZ)
Title: Vector comprising repeating DNA array of greater than 20kB, host cell, and method
Inventor: HARRINGTON JOHN J
IPC: C12N15/85
Filed: 1997-09-22
Abstract: A method of stably cloning large arrays of repetitive DNA into microorganisms. The repeating unit, and especially the higher order repeating unit, that is the basis of the tandem array contains complementary, but non-isoschizomeric restriction sites at opposing ends. Such ends may be designed into the unit using methods such as PCR. The method is especially useful for the stable cloning of alpha satellite DNA.
Patent NZ-501776-A (NZ)
Title: Spring probe and methods for arraying oligonucleotide and thickening agent to a solid support
Inventor: MOYNIHAN KRISTEN
IPC: B01L3/00
Filed: 1998-07-21
Abstract: A method for depositing biomolecules onto a solid support including steps of: immersing a tip of a spring probe into a solution containing biomolecules; removing the tip from the solution so the solution adheres to the tip; and contacting the biomolecule solution with a solid support thereby transferring the biomolecule solution from the tip to the solid support is described.  The spring probe has a planar tip but is otherwise identical to commercial spring probes.  The biomolecule solution contains a thickening agent in addition to the biomolecules, which are preferably oligonucleotides. Fig. 2A is an isometric view showing a preferred apparatus and method for selectively delivering discrete, controlled volumes of a biomolecular solution onto the PEI layer (30) over the solid support (20) of the array (10). The apparatus has a spring probe (50) operatively attached to an actuator (60) and a delivery tip (70) attached to an opposing end of the spring probe (50). Fig. 2B is an enlarged front elevational view of a delivery tip (70) in accordance with one embodiment.  The delivery tip (70) preferably has a truncated-conical shape with a distal face (72) and a plurality of flutes or channels (74).
Patent NZ-504215-A (NZ)
Title: Method and system of encoding and processing alternative healthcare provider billing with generation of billing code by combining a number of codes obtained from different sources into single billing code
Inventor: GIANNINI JO MELINNA
Filed: 1997-10-30
Abstract: A system (10) is disclosed for encoding and encompassing healthcare provider billing, more particularly, a computer assisted network for encoding, documenting and processing claims (18) for payment of specific procedures by alternative therapy providers (12), grouped geographically and by specialty. The system (10) employs a computer accessing three main databases (14, 16, 20) for identifying, encoding and calculating the average cost for provider services (58). A resulting Alternative Billing Code (ABC) is produced which can be compared and correlated with insurance industry standard codes (40). The ABC is an assembly of a series of terms and sub-terms from databases (14, 16, 20), namely Alternative Practice Type (APT) (14), Standard Alternative Procedure Descriptions (SAPDs) (16), Provider Data (PD) (20) and RVU (Relative Value Unit) databases. Each provider specialty includes its own listing of treatments which are turned into RVUs, thus establishing a sequence of treatment fees and charges. The APT code and SAPD code are stored in a PD file including average claim costs of all providers as categorized by a predetermined grouping, which with the PD create the ABC as a comprehensive, single code representing all elements of treatment incident to a patient visit. Claims (18) for payment are submitted and translated into an appropriate code for determination of payment under the present system.
Patent NZ-507913-A (NZ)
Title: Novel nucleosides having bicyclic sugar moiety
Inventor: WANG GUANGYI
IPC: A61K31/00
Filed: 1999-05-24
Abstract: A nucleotide of formula I wherein, X, Y and Z are independently selected from a group consisting of O, S, CH2, NR, C=O, C=CH2 or a bond, where R is selected from a group comprising hydrogen, alkyl, alkenyl, alkynyl and acyl; R1 is selected from a group comprising adenine, cytosine, guanine, hypoxanthine, uracil, thymine, heterocycles; and R2 and R3 are independently selected from a group comprising H, OH, DMTO, TBDMSO, BnO, AcO, BzO, OP(NiPr2)O(CH2)2CN, OPO3H, diphosphate, triphosphate; R2 and R3 together may be PhCHO2, TIPDSO2 or DTBSO2. Oligonucleotides comprising the nucleotides may be used as antiviral compositions.
Patent NZ-508813-A (NZ)
Title: Flexible shaft coupling element and flexible couplings incorporating same
Inventor: CLARKE ARTHUR JACK
IPC: F16D3/74
Filed: 1999-06-17
Abstract: A flexible, elastomeric shaft coupling element (42) comprises a flexible sleeve shaped annular portion (46) with two opposed coupling receiving portions (48,50) having axially extending internal ribs or teeth (56) wherein each tooth has a length and circumferential width which define a tooth shear area, the sum of which possesses a cumulative shear capacity which is in excess of the torsional shear capacity of the annular portion. Preferably, fibres are incorporated in the elastomer. Also described are couplings incorporating the element (42) and a method for forming said element.
Patent NZ-510115-A (NZ)
Title: Tricyclic delta3-piperidines as alpha2-antagonists useful in the treatment of depression and Parkinson's disease
Inventor: KENNIS LUDO EDMOND JOSEPHINE
IPC: A61P3/10
Filed: 1999-10-01
Abstract: Compounds of formula (I), the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof are disclosed, wherein Alk is C1-6 alkanediyl; n is 1 or 2; X1 is -O-, -S-, -S(=O)- or -S(=O)2-; each R1 is independently hydrogen, halogen, C1-6 alkyl, nitro, hydroxy or C1-4 alkyloxy; D is an optionally substituted mono, bi- or tricyclic nitrogen containing heterocycle, a 2H-benzopyranone, a benzamide, a benzophenone or a phenoxyphenyl having central alpha 2-adrenoceptor antagonist activity. It further relates to their preparation, pharmaceutical use and compositions.  These compounds are useful for treating depression and Parkinson's disease.
Patent NZ-512854-A (NZ)
Title: Side closure for vehicle bodies
Inventor: VANDERLOO THEODORUS JEROEN
IPC: B60J5/06
Filed: 1999-12-07
Abstract: A side closure system for lorries with load receiving tray (30), comprising an integrated support structure with a roller system, support columns (6), multiple side closure sections along each side of the tray (30), each side closure section comprising pivotal arms (27), weatherproof assembly and a lower side board (31) cooperating therewith to provide in a first situation a secure and protected side closure in an expanded travel position and in a second collapsed situation, an unimpeded access to the tray (30), the weatherproof assembly having a handle operated lifting device based on a substantially central upright member (1) with a telescopic counter balance bias mechanism (5) to assist in expanding and collapsing of pivotal arms (27) and weatherproof assembly, the lower side board (31) having locking mechanisms (14) for retaining it in travel position, a further locking mechanism (24) to restrain the central upright member (1) in travel position.
Patent NZ-525585-A (NZ)
Title: A nucleic acid encoding a ID 1protein from ryegrass (Loium) or fescue (Festuca) species
Inventor: SPANGENBERG GERMAN
IPC: C07K14/415
Filed: 2001-11-07
Abstract: A substantially purified or isolated nucleic acid encoding Indeterminate1 ( ID1 ), a putative transcriptional regulator of flowering transition, and its polypeptide sequence from a ryegrass (Lolium) species are described. Vectors and plant cells comprising the nucleic acid are described. The nucleic acid can be introduced into a plant to modify plant life cycles and growth phases in a plant, i.e. flowering processes, flowering and plant architecture inflorescence and flower development or can be used as a molecular marker.
Patent NZ-528077-A (NZ)
Title: Use of tenascin-C nucleic acid ligands
Inventor: HICKE BRIAN
IPC: C12Q1/68
Filed: 2000-01-29
Abstract: Methods are described for the identification and preparation of nucleic acid ligands to tenascin-C, in particular specific RNA ligands to tenascin-C identified by the SELEX method. Further described are methods for detecting the presence of a disease condition in a biological tissue in which tenascin-C is expressed. Also described is the use of therapeutic agent- tenascin-C nucleotide ligand complex for the manufacture of a medicament for the delivery of a therapeutic agent to a disease that is expressing tenascin-C such as cancer, psoriasis and atherosclerosis. (62) Divided out of 516907
Patent NZ-528818-A (NZ)
Title: Use of rare earth metal ions for the prevention of kidney stone disease
Inventor: ABRAMS MICHAEL J
IPC: A61K33/244
Filed: 2002-04-22
Abstract: Provided is the use of an effective non-toxic amount of a salt of a rare earth metal and one or more non-toxic counter ions, which salt is optionally hydrated, for manufacture of a medicament for use in treating a condition characterised by unwanted absorption of oxalate from the gastrointestinal tract of a subject in the absence of hyperphosphatemia; wherein the subject has been diagnosed as exhibiting said unwanted absorption of oxalate but the subject does not exhibit hyperphosphatemia; and wherein said rare earth metal is selected from La, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y and Sc and the subject (a) is at risk for oxalate kidney stones, (b) exhibits symptomology of kidney stones, (c) has confirmed diagnoses of kidney stones, or (d) is suspected by virtue of alternative symptoms of having kidney stones. Further provided is similar use of a lanthanum carbonate of the formula [La]a[X]b·cH2O wherein c is 0-10.
Patent NZ-530490-A (NZ)
Title: New compounds, which are potent inhibitors of Na+/Ca2+ exchange mechanism and are useful in the treatment of arrhythmias
Inventor: KOSKELAINEN TUULA
IPC: C07C217/14
Filed: 2002-07-10
Abstract: Therapeutically active compounds of formula (I): wherein X is -O-, -CH2- or -C(O)-; Z is -CHR9- or valence bond; Y is -CH2-, -C(O)-, CH(OR10)-, -CH(NR11R12)-, -O-, -S-, -S(O)- or -S(O2)-, provided that in case Z is a valence bond, Y is not C(O); the dashed line represents an optional double bond in which case Z is -CR9- and Y is -CH-, C(OR10)- or -C(NR11R12)-; R1 is one of the groups having the structure as defined in the specification or when X is -O- and Z is -CH2- R1 is also -(CH2)nNR4R7; n is 1-4; R2 and R3 are independently H, C1-7 alkyl, C1-7 alkoxy, -NO2, halogen, -CF3, -OH, -NHR8 or -COOH; R4 and R7 are independently H, C1-7 alkyl or C1-7 hydroxyalkyl; R5 is H, C1-7 alkoxy, -CF3, -NH2 or -CN; R6 is -NO2 , -NR14R19, -CF3 or the group having the structure as defined in the specification; R8 and R16 are independently H or C1-7 acyl; R9 is H or C1-7 alkyl; R10 is H, alkylsulfonyl or C1-7 acyl; R11 and R12 are independently H, C1-7 alkyl or C1-7 acyl; R13 and R18 are independently H or -OR20; R14 and R19 are independently H, C1-7 acyl, C1-7 alkylsulfonyl, C(S)NHR17 or C(O)NHR17; R15 is H or NH2; R17 is H or C1-7 alkyl; R20 is H or C1-7 acyl; and pharmaceutically acceptable salts and esters thereof are disclosed. These compounds are potent inhibitors of Na+/Ca2+ exchange mechanism in a cell and are suitable for the treatment of arrhythmias.
Patent NZ-532222-A (NZ)
Title: Apparatus and methods for remote installation of devices for reducing drag and vortex induced vibration
Inventor: MCDANIEL RICHARD BRUCE
IPC: E21B41/04
Filed: 2002-10-18
Abstract: Apparatus and methods for remotely installing vortex-induced vibration (VIV) reduction and drag reduction devices (950) on elongated structures (810) in flowing fluid environments. The apparatus is a tool for transporting and installing the devices. The devices installed can include clamshell-shaped strakes (500), shrouds, fairings (810), sleeves and flotation modules.
Patent NZ-533522-A (NZ)
Title: Power inverter
Inventor: WOBBEN ALOYS
IPC: H02M7/00
Filed: 2002-12-11
Abstract: One aspect of the present invention concerns an inverter for converting a directing current into an alternating current. In one aspect, in order to provide an inverter which can be repaired more quickly and more reliably at the location of use, an inverter is of an at least partially modular structure, with releasably installed modules and connecting lines releasably mounted to the modules.
Patent NZ-534982-A (NZ)
Title: Vinyl ester adhesive compositions
Inventor: CHABUT BARBARA
IPC: C09J4/06
Filed: 2003-11-07
Abstract: A curable adhesive composition for anchoring materials in or to concrete or masonry comprising: a. polymerizable vinyl ester corresponding to formula (III), wherein Ar is substituted or unsubstituted aromatic radical with a valence of at least two, R is independently a substituted or unsubstituted divalent radical derived from alkyl or arylalkyl, R3 is a hydroxyl substituted divalent radical derived from an alkyl radical, R4 is independently a vinyl carboxy radical or a epoxy radical, or R, provided that the ratio of n to the number of vinyl carboxy R4 groups is, on average for the composition, from about 0.4 to about 2.0, and n is from 1 to 5; b. an ethylenically unsaturated monomer reactive with said polymerizable vinyl ester; c. curing catalyst; and d. activator, is disclosed.
Patent NZ-536340-A (NZ)
Title: Factor VII or VIIa polypeptide variants with N-glycosylation
Inventor: HAANING JESPER MORTENSEN
IPC: A61P17/02
Filed: 2003-04-29
Abstract: A factor VII or Factor VIIa polypeptide variant having an amino acid sequence comprising 3-15 amino acid modifications relative to human Factor VII or human Factor VIIa having the amino acid sequence shown in SEQ ID NO:2. The amino acid sequence of the variant comprises the amino acid substitutions P10Q and K32E and a sugar moiety is covalently attached to an introduced in vivo N-glycosylation site located outside the Gla domain and is introduced by at least one substitution selected from the group consisting of A51N, G58N, T106N, K109N, G124N, K143+N145T, A175T, I205T, V253N, T267N, T267N+S269T, S314N+K316S, S314N+K316T, R315N+V317S, R315N+V317T, K316N+G318S, K316N+G318T, G318N and D334N. Also described are nucleotide sequences encoding the factor VII or Factor VIIa polypeptide variants, expression vectors comprising the nucleotide sequences, host cells comprising the nucleotide sequences and use of the variants in a medicament for the treatment of a disease or disorder where clot formation is desirable.
Patent NZ-540647-A (NZ)
Title: Combination ladders, ladder components and methods of manufacturing same
Inventor: BOWERS JACK W
IPC: E06C7/06
Filed: 2003-11-11
Abstract: Ladder configurations and components are provided including an outer rail assembly which is longitudinally adjustable relative to an inner rail assembly. The outer rail assembly includes a pair of spaced-apart outer rails each fixedly coupled to an associated sleeve or sliding mechanism. Each sleeve is in turn slidably coupled to an inner rail of the inner rail assembly. The outer rails may be positioned and oriented at an acute angle relative to the inner rails so as to provide an increased base distance between the two outer rails. Support structures are also disclosed which are coupled at multiple locations along a rail member and at least one location of a rung. Additionally, ladder hinges are disclosed, including hinge components configured to effectively transmit loads from associated rails. In one embodiment, the hinge may include a pinch prevention mechanism.
Patent NZ-543040-A (NZ)
Title: Method for selecting a window or door system based on thermal efficiency
Inventor: PALMER WENDY
Filed: 2005-10-17
Abstract: A method for selecting a window or door system based on a user's thermal efficiency requirements is disclosed. A user enters information regarding thermal efficiency, such as the climate zone in which the door or window system will be used. From these entries a thermal efficiency requirement is calculated and a database is queried to return suitable door or window systems.
Patent NZ-546541-A (NZ)
Title: Locating system utilising adjustable transmission power in a micro-cellular network
Inventor: BUTTS MICHAEL STEWART
IPC: H04W4/33
Filed: 2004-09-17
Abstract: A communications system for mobile units (MU) within a facility is disclosed. The communications system for mobile units (MU) within a facility comprises a central controller (FP server) and a plurality of wireless base stations (BS1-BS11) that have adjustable transmission power, where the base stations (BS1-BS11) are distributed throughout the facility for wireless communication with the controller (FP server) and the mobile units (MU). The controller (FP server) configures the base stations (BS1-BS11) into a plurality of micro- cells (MC1-MC6), each including at least two base stations (BS1-BS11), by adjusting the wireless transmission power of the base stations (BS1-BS11) such that at least one base station (BS1-BS11) in each micro-cell (MC1-MC6) is a member of another micro-cell (MC1-MC6). At least one base station (BS1-BS11) is able to communicate with the central controller (FP server), and all mobile units (MU) within a selected area of the facility are able to communicate with at least one base station (BS1-BS11).
Patent NZ-547503-A (NZ)
Title: Method of detecting an off-balance condition of a clothes load in a washing machine
Inventor: STANSEL ANDREW C
Filed: 2006-05-25
Abstract: A method for detecting an off-balance load condition of a clothes load in a washing machine 100 using frequency analysis is disclosed. The washing machine rotates a wash basket 106 within a tub 102. The off balance condition is detected by extracting at least one frequency representative of an off-balance condition from a multiple frequency signal representative of the rotational speed of the wash basket.
Patent NZ-552699-A (NZ)
Title: Bicycle saddle
Inventor: RIONDATO FRANCESCO
IPC: B62J1/00
Filed: 2005-07-28
Abstract: A bicycle saddle is disclosed. The saddle has two longitudinally symmetrical portions, and has a long central channel at the front part of its median zone. Each of the portions includes a rear part, such that the two rear parts: are reciprocally united by a hollow; are sloped in an upward direction adjacent the hollow; provide a substantially flat area adjacent the sides of the substantially flat area; slope in relation to the vertical line by behind the hollow; and provide a recess, such that the rear ends of the two parts are separated. Each of the portions also includes a front portion in sloping relation with its rear part, such that each of the front portions is sloped upwards. The front portions are separated. The sides of each front portion slopes downwards approximately perpendicularly to its top surface. The front end of each front portion slopes downwards in a substantially hook shaped curve. The front ends unite in an approximately semi-circular form having a first diameter. The portions define the central channel such that adjacent the hollow the central channel presents a zone in semi-circular form, from an intermediate point to the front ends, and the central channel includes a narrower part.
Patent NZ-555386-A (NZ)
Title: Formulations of human growth hormone comprising a non-naturally encoded amino acid
Inventor: LITZINGER DAVID C
IPC: A61K38/27
Filed: 2005-12-21
Abstract: Disclosed is a pharmaceutical formulation of a human growth hormone (hGH) variant, wherein said formulation comprises: a. a pharmaceutically effective quantity of a hGH variant polypeptide comprising a non-naturally encoded amino acid (NEAA) consisting of p-acetyl phenylalanine (pAF) at a position equivalent to position 35 of hGH comprising an amino acid sequence set forth in SEQ ID NO:2; b. a buffer; and c. at least one carrier, excipient or stabilizer.
Patent NZ-555899-A (NZ)
Title: Bio-diesel fuel production and apparatus thereof
Inventor: CHOU CHIH-CHUNG
IPC: C12M1/40
Filed: 2005-09-20
Abstract: A system for generating alkyl ester is disclosed, which comprises: a cartridge to receive a mixture comprising a first reactant and a second reactant, the cartridge including an enzyme to facilitate a reaction between the first and second reactants to generate a reaction product, the cartridge having an identifier; and a controller to control an operation condition of the system based on the identifier on the cartridge. The system can be incorporated into an apparatus for producing an alkyl ester via a transesterification or esterification reaction. The alkyl ester produced can be used as a bio-diesel fuel.
Patent NZ-560747-A (NZ)
Title: Diagnostic circuit
Inventor: ALVORD ROBERT J
IPC: G08B21/00
Filed: 2006-03-20
Abstract: A diagnostic circuit is disclosed. The diagnostic circuit comprises resistors and a capacitor. The diagnostic circuit is monitored to detect the presence of a load and to confirm the proper operation of a relay circuit. The diagnostic circuit generates an oscillating voltage when the relay circuit is open and the load is connected, generates a logic low when the relay circuit is open and the load is disconnected, and generates a logic high when the relay circuit is closed. The diagnostic circuit can be disposed within a diagnostic circuit system that includes one or more of a sensing circuit, a relay circuit, an alternating-current source having a direct current offset, an input circuit, and a high-voltage microprocessor. The high-voltage microprocessor can be bi-directionally optically coupled to an application microprocessor.
Patent NZ-562796-A (NZ)
Title: Method of determining whether a compound is a neurotrypsin inhibitor using agrin
Inventor: SONDEREGGER PETER
IPC: G01N33/00
Filed: 2006-03-29
Abstract: Disclosed is a method for determining whether a compound is a neurotrypsin inhibitor, wherein the compound is incubated together with neurotrypsin, a variant thereof retaining the neurotrypsin activity or a fragment comprising the protease domain of neurotrypsin and with a protein or peptide comprising agrin, a variant thereof retaining the agrin activity or a fragment comprising the alpha- or the beta-cleavage site of agrin, in an aqueous buffer solution, the amount of cleavage of agrin is measured, and the compound is determined to be a neurotrypsin inhibitor if the amount of cleavage of agrin is reduced compared to a reaction in which the compound is omitted.
Patent NZ-563053-A (NZ)
Title: Device to assist in changing a baby where a shield with a hole for the torso isolates one end of the baby from the other
Inventor: ROGERS DIGORY PETER
IPC: A47D5/00
Filed: 2006-03-29
Abstract: An apparatus for facilitating the changing of a baby's soiled sanitary wear is disclosed. The apparatus comprises a lamina (101) including a recess (106) adapted to receive the torso of a baby whose soiled sanitary wear is to be changed. Lamina-positioning means (103, 104) for positioning the lamina (101) transversely of and orthogonal to a base member (102) are supplied. The lamina-positioning means are a pair of collapsible supports (103, 104) positioned on either side of each end of the lamina (101). The recess (106) in the lamina (101) is edged with a resilient cellular material (107) encapsulated with a cleanable envelope.
Patent NZ-564342-A (NZ)
Title: Seperating a process stream using a stochastic cellular solid material with specific pore size
Inventor: GLOVER JOHN H
IPC: B01J8/26
Filed: 2006-05-22
Abstract: Disclosed are methods for separating a process stream into one or more component streams in a component separation unit. The method comprises the steps of: positioning at least one bed of stochastic three dimensional cellular sold material within the unit, the material having a solid component and one or more cells; passing the stream through the bed; and recovering the stream from the unit. The composition of one or more phases in the unit is changed as they pass through the solid material, producing a component stream with a desired composition. The solid material has a pore size between 100 to 6000 microns. A separation assembly unit to achieve this method is also disclosed, as well as a method where the phases are contacted at a surface of the material to facilitate mass transfer.